4/A: Herbalife Amends President's SARs Exercise Price

Herbalife Ltd. filed an amendment to correct the exercise price of President Robert Levy's Stock Appreciation Rights from $10.51 to $19.26.

Summary

• An amendment to a Form 4 was filed by Robert Levy, President of Herbalife Ltd.
• The amendment's sole purpose is to correct the exercise price of Stock Appreciation Rights (SARs).
• The previously reported exercise price of $10.51 has been corrected to $19.26.
• The transaction involved the acquisition of 33,301 SARs on February 25, 2026.
• These SARs will vest in one-third increments on February 25, 2027, February 25, 2028, and February 25, 2029, contingent on continued service.
• No other information from the original Form 4 was changed.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is solely an administrative correction of a previously reported insider transaction, with no new operational or financial information.

Future Outlook

No specific future outlook or guidance is provided in this amendment.

Industry Context

StockSavvy.ai notes that Form 4/A filings are routine for correcting administrative errors in insider transaction reports. This specific amendment, correcting an exercise price, does not inherently reflect broader industry trends but rather a specific administrative detail related to executive compensation at Herbalife.

Comparison to Industry Standards

• This filing is an administrative correction of an insider transaction. It does not contain information that allows for a direct comparison to industry-standard operational or financial results.

Stakeholder Impact

• Shareholders: Minimal direct impact, as it's an administrative correction of an existing executive compensation detail.
• Management: The correction impacts the specific executive's compensation details.

Next Steps

• Vesting of SARs in one-third increments on February 25, 2027, February 25, 2028, and February 25, 2029, subject to continued service.

Key Dates

Recommendation

This filing is an administrative correction of an insider transaction and provides no new material information regarding the company's operational performance, financial health, or strategic direction. Therefore, it does not warrant a change in investment recommendation.

Keywords

Herbalife, HLF, Form 4/A, SEC filing, Stock Appreciation Rights, SARs, Robert Levy, insider transaction, executive compensation, equity compensation, amendment